comprehensive -WSS

comprehensive

author：comprehensive 2025-09-03 03:40:56 - browse：9138

Adam's take main illustration — Molly Ferguson/STAT

Some day-after thoughts on Bristol Myers Squibb acquiring Mirati Therapeutics:

A take-under deal feels meh for biotech sector sentiment.Bristol is paying $58 per share in cash for Mirati, which closed Friday at $60. Granted, Mirati was trading in the $30 range in September, so from there, the roughly 50% premium isn’t terrible. But as Mizuho strategist Jared Holz pointed out, investors would liked to have seen Mirati go for $75-$100 per share.

With the closely watched XBI biotech index down 13% for the year, every M&A deal helps improve sentiment, but this one — maybe just a little. Bristol is paying $4.8 billion in cash to acquire Mirati, or $3.7 billion after accounting for Mirati’s cash. It’s a small bolt-on acquisition for Bristol, which isn’t overpaying.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medicare proposal to cover medical devices draws a mixed reaction
Next article： Families look for replacement for GSK asthma drug Flovent

knowledge

hotspot

focus

WSS

A new approach to psychiatric drug development

The untold story of TV’s first prescription drug ad

The untold story of TV’s first prescription drug ad

Thousands of Marines and sailors deploy to Middle East to deter Iran from seizing ships

Families look for replacement for GSK asthma drug Flovent

Arizona Democrat to raise extreme heat with Biden 1 year out from Senate primary

entertainment

comprehensive

entertainment

Anesthesiologist group: stop taking Ozempic before surgery

The public health thinking behind the CDC’s new Covid guidance

FDA approval of Sarepta Duchenne genetic therapy gives me hope

The untold story of TV’s first prescription drug ad

Cancer drug shortages should be causing more outrage

Longer MASH drug regimen improved liver, Akero study finds

The high cost of giving birth even with insurance

Elon Musk says he may need surgery before proposed 'cage match' with Mark Zuckerberg

Medicare proposal to cover medical devices draws a mixed reaction

Elon Musk says he may need surgery before proposed 'cage match' with Mark Zuckerberg

leisure time

Prince Harry and Meghan to work on film adaptation of 'Meet Me at the Lake' novel

Elon Musk says he may need surgery before proposed 'cage match' with Mark Zuckerberg

Biden's 'march

$1 billion proposal to grow Boston, Massachusetts biotech

For AI in health care standards, federal regulators join with industry group

Prince Harry and Meghan to work on film adaptation of 'Meet Me at the Lake' novel

knowledge

hotspot

focus

hotspot